NO20060377L - Polymorphs of donepezil hydrochloride and processes for their preparation - Google Patents
Polymorphs of donepezil hydrochloride and processes for their preparationInfo
- Publication number
- NO20060377L NO20060377L NO20060377A NO20060377A NO20060377L NO 20060377 L NO20060377 L NO 20060377L NO 20060377 A NO20060377 A NO 20060377A NO 20060377 A NO20060377 A NO 20060377A NO 20060377 L NO20060377 L NO 20060377L
- Authority
- NO
- Norway
- Prior art keywords
- polymorphs
- donepezil hydrochloride
- processes
- preparation
- peaks
- Prior art date
Links
- 229960003135 donepezil hydrochloride Drugs 0.000 title abstract 2
- XWAIAVWHZJNZQQ-UHFFFAOYSA-N donepezil hydrochloride Chemical compound [H+].[Cl-].O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 XWAIAVWHZJNZQQ-UHFFFAOYSA-N 0.000 title abstract 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 abstract 2
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 238000000862 absorption spectrum Methods 0.000 abstract 1
- 238000000634 powder X-ray diffraction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Donepezil hydrochloride, 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride, is provided here in the form of four polymorphs which are stable against heat and humidity in the pharmaceutical use. They can be industrially produced. They are specified by peaks in X-ray powder diffraction pattern and absorption peaks in infrared absorption spectra in potassium bromide.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14629396 | 1996-06-07 | ||
PCT/JP1996/003881 WO1997046526A1 (en) | 1996-06-07 | 1996-12-27 | Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production |
US08/774,802 US6140321A (en) | 1996-06-07 | 1996-12-30 | Polymorphs of donepezil hydrochloride and process for production |
PCT/JP1997/001932 WO1997046527A1 (en) | 1996-06-07 | 1997-06-06 | Polymorphs of donepezil hydrochloride and process for production |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20060377L true NO20060377L (en) | 1999-01-28 |
Family
ID=26477192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20060377A NO20060377L (en) | 1996-06-07 | 2006-01-24 | Polymorphs of donepezil hydrochloride and processes for their preparation |
Country Status (10)
Country | Link |
---|---|
CN (1) | CN1207282C (en) |
AT (1) | ATE230396T1 (en) |
CY (1) | CY2316B1 (en) |
CZ (1) | CZ296619B6 (en) |
DE (1) | DE69718216T2 (en) |
NO (1) | NO20060377L (en) |
PL (1) | PL330362A1 (en) |
PT (1) | PT1019374E (en) |
TR (2) | TR200202374T2 (en) |
TW (1) | TWI243816B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101906066B (en) * | 2010-08-08 | 2015-03-11 | 浙江华海药业股份有限公司 | Method for preparing donepezil hydrochloride crystal form I |
CN102060752B (en) * | 2011-01-24 | 2013-03-13 | 上海右手医药科技开发有限公司 | Method for producing high-purity donepezil hydrochloride anhydrous I type crystal form and product thereof |
CN103012247B (en) * | 2013-01-18 | 2014-12-10 | 浙江东亚药业有限公司 | Method for preparing donepezil hydrochloride in anhydrous I crystal formation |
CN103694164B (en) * | 2014-01-23 | 2015-08-12 | 天津大学 | A kind of New crystal form of donepezil hydrochloride and preparation method |
CN107550884B (en) * | 2017-09-19 | 2018-06-05 | 扬子江药业集团上海海尼药业有限公司 | A kind of Doneppezil Hydrochloride capsule and preparation method thereof |
-
1997
- 1997-06-05 TW TW089110397A patent/TWI243816B/en not_active IP Right Cessation
- 1997-06-06 CZ CZ0396098A patent/CZ296619B6/en not_active IP Right Cessation
- 1997-06-06 DE DE69718216T patent/DE69718216T2/en not_active Expired - Lifetime
- 1997-06-06 CN CNB971952639A patent/CN1207282C/en not_active Expired - Lifetime
- 1997-06-06 AT AT97924337T patent/ATE230396T1/en active
- 1997-06-06 TR TR2002/02374T patent/TR200202374T2/en unknown
- 1997-06-06 TR TR1998/02531T patent/TR199802531T2/en unknown
- 1997-06-06 PT PT97924337T patent/PT1019374E/en unknown
- 1997-06-06 PL PL97330362A patent/PL330362A1/en unknown
-
2003
- 2003-02-07 CY CY0300012A patent/CY2316B1/en unknown
-
2006
- 2006-01-24 NO NO20060377A patent/NO20060377L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PT1019374E (en) | 2003-03-31 |
TWI243816B (en) | 2005-11-21 |
CZ296619B6 (en) | 2006-05-17 |
DE69718216T2 (en) | 2003-10-09 |
DE69718216D1 (en) | 2003-02-06 |
CN1221404A (en) | 1999-06-30 |
CY2316B1 (en) | 2003-11-14 |
PL330362A1 (en) | 1999-05-10 |
CZ396098A3 (en) | 1999-03-17 |
ATE230396T1 (en) | 2003-01-15 |
CN1207282C (en) | 2005-06-22 |
TR200202374T2 (en) | 2003-01-21 |
TR199802531T2 (en) | 1999-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1211243T3 (en) | Polymorphs of Donepezil Hydrochloride and Methods of Preparation thereof | |
CA2252806A1 (en) | Polymorphs of donepezil hydrochloride and process for production | |
NO20060377L (en) | Polymorphs of donepezil hydrochloride and processes for their preparation | |
NO982712D0 (en) | Methods and intermediates for the preparation of 1-benzyl-4 - ((5,6-dimethoxy-1-indanone) -2-yl) methylpiperidine | |
HUP0000610A3 (en) | Piperidine derivatives, with analgesic effect, process for producing them and pharmaceutical compositions containing them | |
NO991761D0 (en) | New piperidine cotocarboxylic acid derivatives, their preparation and use | |
GB8904163D0 (en) | Piperazine derivative or its sait,process for producing the same and pharmaceutical composition comprising the same as active ingredient | |
NZ238884A (en) | Piperidine, tetrahydropyridine and pyrrolidine derivatives and | |
NO983261D0 (en) | New Benzoylguanidine Derivatives, Methods of Preparing Them and Using Them in the Preparation of Medicines | |
DE602004024129D1 (en) | 1-BENZYL-4-Ä (5,6-DIMETHOXY-1-INDANONE) -2-YL-METHYLPIPERIDINE OXALATE AND ITS POLYMORPHES | |
NO984861L (en) | Piperidines and pyrrolidines | |
NO982708D0 (en) | Novel phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals | |
NO970023D0 (en) | Process for preparing an anatase titanium dioxide and anatase titanium dioxide obtained thereby | |
EP0714890A3 (en) | Process and the preparation of 4-amino-2,2,6,6-tetra-methyl piperidine | |
FI903333A7 (en) | Piperidine derivative, method for its preparation and pharmaceutical composition containing it | |
NO20002450L (en) | Composition of active ingredients, in particular tetrahydropyridines and acetylcholinesterase inhibitors, for the treatment of senile dementia of Alzheimer's type | |
AP2000002017A0 (en) | Salts of paroxetine. | |
FI941912L (en) | 3-Quinolyl-substituted dihydropyridines, process for their preparation and their use in pharmaceuticals | |
DK0515940T3 (en) | New 2-amino-5-cyano-1,4-dihydropyridines, process for their preparation and use in pharmaceuticals | |
HUP0002270A2 (en) | Polymorphs of donepezil hydrochloride and process for production and pharmaceutical compositions containing them | |
PL303978A1 (en) | Novel derivatives of piperidine and piperazine, method of obtaining them as well as pharmaceutical preparation and method of obtaining same | |
DK0452850T3 (en) | 4- [3- (Oxothiazoldinyl)] butynylamines, process for their preparation and their use as pharmaceuticals | |
NO941134L (en) | 1,2,5,6-tetrahydropyridine derivative, process for its preparation, and its therapeutic uses | |
EP1316549A4 (en) | 1-benzyl-4-[(5,6-dimethoxy-2-fluoro-1-indanon)-2-yl] methylpiperidine | |
DK32886D0 (en) | 3- (PIPERIDINYL) - OR 3- (PYRROLIDINYL) -1H-INDAZOLES, OPTICAL ANTIPODES OR PHARMACEUTICAL ACCEPTABLE SALTS THEREOF, THEIR PREPARATION AND USE AS PHARMACEUTICALS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |